Translational strategies for identifying chemically reactive metabolites as cause for Adverse Drug Reactions

被引:0
|
作者
Vermeulen, Nico P. E. [1 ]
机构
[1] Vrije Univ Amsterdam, Dept Chem & Pharmaceut Sci, AIMMS Sect Mol Toxicol, Amsterdam, Netherlands
关键词
D O I
10.1016/j.toxlet.2013.06.100
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
引用
收藏
页码:S28 / S28
页数:1
相关论文
共 50 条
  • [1] Reactive metabolites and adverse drug reactions - Clinical considerations
    Knowles, SR
    Shapiro, LE
    Shear, NH
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2003, 24 (03) : 229 - 238
  • [2] Analytical strategies for the screening and evaluation of chemically reactive drug metabolites
    Wen, Bo
    Fitch, William L.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (01) : 39 - 55
  • [3] The role of reactive drug metabolites in immune-mediated adverse drug reactions
    Hess, DA
    Rieder, MJ
    ANNALS OF PHARMACOTHERAPY, 1997, 31 (11) : 1378 - 1387
  • [4] Pharmacogenomic factors affecting adverse drug reactions involving reactive metabolites
    Daly, A.
    TOXICOLOGY LETTERS, 2015, 238 (02) : S19 - S19
  • [5] ADVERSE DRUG EFFECT - REACTIVE METABOLITES AND IDIOSYNCRATIC DRUG-REACTIONS .1.
    GIBALDI, M
    ANNALS OF PHARMACOTHERAPY, 1992, 26 (03) : 416 - 421
  • [6] Analytical strategies for identifying drug metabolites
    Prakash, Chandra
    Shaffer, Christopher L.
    Nedderman, Angus
    MASS SPECTROMETRY REVIEWS, 2007, 26 (03) : 340 - 369
  • [7] Reactive metabolites and their role in drug reactions
    Naisbitt, Dean J.
    Williams, Dominic P.
    Pirmohamed, Munir
    Kitteringham, Neil R.
    Park, B. Kevin
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 1 (04) : 317 - 325
  • [8] Reactive metabolites and adverse drug reactionsClinical considerations
    Sandra R. Knowles
    Lori E. Shapiro
    Neil H. Shear
    Clinical Reviews in Allergy & Immunology, 2003, 24 : 229 - 238
  • [9] Managing the challenge of chemically reactive metabolites in drug development
    B. Kevin Park
    Alan Boobis
    Stephen Clarke
    Chris E. P. Goldring
    David Jones
    J. Gerry Kenna
    Craig Lambert
    Hugh G. Laverty
    Dean J. Naisbitt
    Sidney Nelson
    Deborah A. Nicoll-Griffith
    R. Scott Obach
    Philip Routledge
    Dennis A. Smith
    Donald J. Tweedie
    Nico Vermeulen
    Dominic P. Williams
    Ian D. Wilson
    Thomas A. Baillie
    Nature Reviews Drug Discovery, 2011, 10 : 292 - 306
  • [10] Managing the challenge of chemically reactive metabolites in drug development
    Park, B. Kevin
    Boobis, Alan
    Clarke, Stephen
    Goldring, Chris E. P.
    Jones, David
    Kenna, J. Gerry
    Lambert, Craig
    Laverty, Hugh G.
    Naisbitt, Dean J.
    Nelson, Sidney
    Nicoll-Griffith, Deborah A.
    Obach, R. Scott
    Routledge, Philip
    Smith, Dennis A.
    Tweedie, Donald J.
    Vermeulen, Nico
    Williams, Dominic P.
    Wilson, Ian D.
    Baillie, Thomas A.
    NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (04) : 292 - 306